Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.
Floyd, K;
Glaziou, P;
Houben, RMGJ;
Sumner, T;
White, RG;
Raviglione, M;
(2018)
Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.
The international journal of tuberculosis and lung disease, 22 (7).
pp. 723-730.
ISSN 1027-3719
DOI: https://doi.org/10.5588/ijtld.17.0835
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
BACKGROUND: Global tuberculosis (TB) targets were set as part of the World Health Organization's End TB Strategy (2016-2035) and the Sustainable Development Goals (2016-2030). OBJECTIVE: To define and explain the rationale for these targets. DESIGN: Scenarios for plausible reductions in TB deaths and cases were developed using empirical evidence from best-performing countries and modelling of the scale-up of under-used interventions and hypothetical TB vaccines. Results were discussed at consultations in 2012 and 2013. A final proposal was presented to the World Health Assembly in 2014 and unanimously endorsed by all Member States. RESULTS: The 2030 targets are a 90% reduction in TB deaths and 80% reduction in TB incidence compared with 2015 levels. The 2035 targets are for reductions of 95% and 90%, respectively. A third target-that no TB-affected households experience catastrophic costs due to the disease by 2020-was also agreed. CONCLUSION: The global TB targets and milestones set for the period 2016-2035 are ambitious. Achieving them requires concerted action on several fronts, but two things are fundamental: 1) progress towards universal health coverage to ensure that everyone with TB can access high-quality treatment; and 2) substantial investment in research and development for new tools to prevent TB disease among the approximately 1.7 billion people infected.